WAKAMOTO PHARMACEUTICAL CO.,LTD.
わかもと製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4512
FY2025 · 2026-03-31
| Gross margin | 47.7% |
| Operating margin | 2.6% |
| Net margin | 2.3% |
| Return on equity | — |
| Return on assets | 1.4% |
| Revenue growth (YoY) | 27.2% |
| EPS (basic) | ¥6.54 |
| EPS growth (YoY) | 253.5% |
| Current ratio | 3.48x |
| Equity ratio | 65.6% |
| Book value / share | ¥346 |
| Free cash flow | -1,051 M |